ISHARES TR's ticker is HDV and the CUSIP is 46429B663. A total of 458 filers reported holding ISHARES TR in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $883,373 | +25.9% | 8,661 | +22.1% | 0.10% | +9.8% |
| Q3 2023 | $701,541 | +1.3% | 7,094 | +3.3% | 0.09% | +4.5% |
| Q2 2023 | $692,225 | +7.0% | 6,868 | +7.9% | 0.09% | 0.0% |
| Q1 2023 | $646,989 | +13.9% | 6,364 | +16.8% | 0.09% | +8.6% |
| Q4 2022 | $567,800 | +19.6% | 5,447 | +4.7% | 0.08% | +9.5% |
| Q3 2022 | $474,757 | -4.7% | 5,201 | +4.9% | 0.07% | +2.8% |
| Q2 2022 | $498,087 | +15.9% | 4,960 | +23.4% | 0.07% | +33.3% |
| Q1 2022 | $429,839 | +19.3% | 4,021 | +12.7% | 0.05% | +20.0% |
| Q4 2021 | $360,342 | +12.5% | 3,568 | +5.0% | 0.04% | 0.0% |
| Q3 2021 | $320,236 | -2.7% | 3,397 | -0.3% | 0.04% | -2.2% |
| Q2 2021 | $329,014 | +2.0% | 3,408 | +0.3% | 0.05% | -6.1% |
| Q1 2021 | $322,542 | +7.7% | 3,399 | -0.5% | 0.05% | -9.3% |
| Q4 2020 | $299,435 | +4.5% | 3,415 | -4.1% | 0.05% | -6.9% |
| Q3 2020 | $286,491 | -0.7% | 3,560 | +0.2% | 0.06% | -10.8% |
| Q2 2020 | $288,398 | +17.8% | 3,554 | +3.8% | 0.06% | +3.2% |
| Q1 2020 | $244,918 | -23.6% | 3,423 | +4.8% | 0.06% | -7.4% |
| Q4 2019 | $320,429 | +4.7% | 3,267 | +0.5% | 0.07% | -2.9% |
| Q3 2019 | $306,017 | +13.6% | 3,250 | +14.0% | 0.07% | +9.4% |
| Q2 2019 | $269,322 | -10.9% | 2,850 | -12.0% | 0.06% | -14.7% |
| Q1 2019 | $302,135 | +17.9% | 3,239 | +6.7% | 0.08% | +2.7% |
| Q4 2018 | $256,166 | +504.6% | 3,036 | +548.7% | 0.07% | +630.0% |
| Q3 2018 | $42,373 | -19.7% | 468 | -24.6% | 0.01% | -23.1% |
| Q2 2018 | $52,755 | +0.6% | 621 | 0.0% | 0.01% | -7.1% |
| Q1 2018 | $52,439 | -6.1% | 621 | +0.3% | 0.01% | -6.7% |
| Q4 2017 | $55,823 | +15.8% | 619 | +10.3% | 0.02% | +7.1% |
| Q3 2017 | $48,218 | +18.6% | 561 | +14.7% | 0.01% | +7.7% |
| Q2 2017 | $40,651 | +34.3% | 489 | +35.5% | 0.01% | +30.0% |
| Q1 2017 | $30,273 | +41.0% | 361 | +38.3% | 0.01% | +25.0% |
| Q4 2016 | $21,467 | +64.0% | 261 | +62.1% | 0.01% | +60.0% |
| Q3 2016 | $13,086 | -1.1% | 161 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $13,226 | +239.0% | 161 | +222.0% | 0.01% | +150.0% |
| Q1 2016 | $3,901 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVS HEALTH Corp | 624,536 | $62,722,000 | 52.01% |
| Angeles Investment Advisors, LLC | 2,162,920 | $217,222,000 | 19.86% |
| Bull Oak Capital, LLC | 162,500 | $16,320,000 | 15.09% |
| Essex Private Wealth Management, LLC | 38,182 | $3,835,000 | 14.33% |
| VAUGHAN & Co SECURITIES, INC. | 145,498 | $14,612,000 | 11.71% |
| SWISS RE LTD | 564,820 | $56,725,000 | 11.35% |
| Rain Capital Management, LLC | 133,852 | $13,443,000 | 9.66% |
| Titus Wealth Management | 189,826 | $19,064,000 | 9.55% |
| MCIA Inc | 182,506 | $18,400,000 | 9.20% |
| Prostatis Group LLC | 55,911 | $5,615,175 | 8.75% |